The BA.5 subvariant makes up nearly 90% of new COVID-19 cases in the U.S., according to the Centers for Disease Control and Prevention. Pfizer and German partner BioNTech have submitted their new COVID-19 booster – that targets the omicron subvariant BA.5 – to the Food and Drug Administration for emergency use authorization, the companies announced Monday. The new boosters may be available “in a few short weeks” to anyone over the age of 12, said White House COVID coordinator Dr. Ashish Jha in an interview with NBC News. Visit the link in bio for more information.